Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
series B
Biotech
Metsera follows phase 1 weight loss data with $215M series B
Metsera is riding the wave of continued enthusiasm for GLP-1 drugs and its own early-stage data to bring in a hefty $215 million series B fundraise.
James Waldron
Nov 13, 2024 9:15am
Inquis Medical draws up $40M to fund blood clot removal system
Nov 5, 2024 12:00pm
AvenCell bags $112M to flick 'switchable' CAR-Ts in the clinic
Oct 22, 2024 6:00am
Seaport loads $225M for Karuna vets' voyage to milestones
Oct 21, 2024 8:05am
ShiraTronics nets $66M for neuromod implant for chronic migraine
Oct 9, 2024 11:00am
Purespring bottles up $105M series B for kidney gene therapy
Oct 9, 2024 2:00am
